Atlantic raises $24M venture round

Atlantic Healthcare plc (Cambridge, U.K.) raised $24 million in a venture round from Lorin Johnson and other founders of Salix Pharmaceuticals Inc., Fullbrook Thorpe Investments, LDC and undisclosed existing investors.

In 2H17, Atlantic expects results from a Phase III study of alicaforsen ( AP 1007) to treat inflammatory bowel disease (IBD) pouchitis. Atlantic has exclusive, worldwide rights to the antisense inhibitor of intercellular adhesion molecule-1 ( ICAM-1; CD54) from Ionis Pharmaceuticals Inc. (NASDAQ:IONS). ...